Accent Capital Management, LLC Novo Cure LTD Transaction History

Accent Capital Management, LLC

  • $238 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$17.82 - $30.19 $908 - $1,539
-51 Reduced 53.13%
45 $802,000
Q3 2024

Nov 06, 2024
SELL
$15.61 - $23.34 $733 - $1,096
-47 Reduced 32.87%
96 $1.5 Million
Q2 2024

Aug 12, 2024
BUY
$11.83 - $24.05 $295 - $601
25 Added 21.19%
143 $2.45 Million
Q4 2023

Mar 19, 2024
BUY
$11.13 - $15.78 $1,313 - $1,862
118 New
118 $1.76 Million

Others Institutions Holding NVCR

# of Institutions
291
Shares Held
74.5M
Call Options Held
1.26M
Put Options Held
247K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email